CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...
With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.
The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.
The collaboration combines Guardant's diagnostics with Trial Library's AI-powered matching and patient navigation platform.
NEW YORK – Finnish diagnostics company Uniogen is on track to seek a CE-IVD mark for an early-stage ovarian cancer detection test by 2027. Currently available for research use only, the firm's Glyvar ...
The study will evaluate the performance of Syantra's blood-based Onco-ID Breast molecular assay for screening women at elevated risk of breast cancer.
The test could potentially deliver noninvasive results in less than one minute through analysis of exhaled volatile organic compounds.
The digital immunoassay platform is designed to detect and quantify proteins at the single-molecule level in blood, serum, or plasma. The platform includes the Simoa HD-X Immunoassay Analyzer, which ...
Last week, readers were most interested in a story about FDA approving Cleveland Diagnostics' prostate cancer test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results